JP2018118936A5 - - Google Patents

Download PDF

Info

Publication number
JP2018118936A5
JP2018118936A5 JP2017012594A JP2017012594A JP2018118936A5 JP 2018118936 A5 JP2018118936 A5 JP 2018118936A5 JP 2017012594 A JP2017012594 A JP 2017012594A JP 2017012594 A JP2017012594 A JP 2017012594A JP 2018118936 A5 JP2018118936 A5 JP 2018118936A5
Authority
JP
Japan
Prior art keywords
polyethylene glycol
enteric
solid preparation
layer
granule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017012594A
Other languages
English (en)
Japanese (ja)
Other versions
JP7064683B2 (ja
JP2018118936A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2017012594A priority Critical patent/JP7064683B2/ja
Priority claimed from JP2017012594A external-priority patent/JP7064683B2/ja
Publication of JP2018118936A publication Critical patent/JP2018118936A/ja
Publication of JP2018118936A5 publication Critical patent/JP2018118936A5/ja
Application granted granted Critical
Publication of JP7064683B2 publication Critical patent/JP7064683B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017012594A 2017-01-27 2017-01-27 腸溶層破損防止用組成物 Active JP7064683B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017012594A JP7064683B2 (ja) 2017-01-27 2017-01-27 腸溶層破損防止用組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017012594A JP7064683B2 (ja) 2017-01-27 2017-01-27 腸溶層破損防止用組成物

Publications (3)

Publication Number Publication Date
JP2018118936A JP2018118936A (ja) 2018-08-02
JP2018118936A5 true JP2018118936A5 (https=) 2020-03-05
JP7064683B2 JP7064683B2 (ja) 2022-05-11

Family

ID=63042993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017012594A Active JP7064683B2 (ja) 2017-01-27 2017-01-27 腸溶層破損防止用組成物

Country Status (1)

Country Link
JP (1) JP7064683B2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020055755A (ja) * 2018-09-28 2020-04-09 日本ケミファ株式会社 腸溶性製剤
WO2020218517A1 (ja) * 2019-04-25 2020-10-29 富士製薬工業株式会社 医薬製剤およびその製造方法
JP2021046372A (ja) * 2019-09-19 2021-03-25 日医工株式会社 エソメプラゾール含有製剤
US20230058473A1 (en) 2020-01-27 2023-02-23 Towa Pharmaceutical Co., Ltd. Esomeprazole oral preparation and method for producing the same
JP7583542B2 (ja) * 2020-07-16 2024-11-14 東和薬品株式会社 機能性薬効粒子およびその製造方法ならびに口腔内崩壊錠
CN114569579B (zh) * 2020-12-02 2023-10-31 丽珠医药集团股份有限公司 肠溶微丸、其制备方法和包含它的制剂
JP7786701B2 (ja) * 2021-06-10 2025-12-16 富士化学工業株式会社 腸溶性の粒状物及びそれを含有する固形製剤
JP2023114904A (ja) * 2022-02-07 2023-08-18 沢井製薬株式会社 エソメプラゾール含有顆粒及びそれを含む口腔内崩壊錠

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69934505T2 (de) * 1998-05-18 2007-10-04 Takeda Pharmaceutical Co. Ltd. Im munde zerfallende tablette enthaltend ein benzimidazole
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
EP1596838A2 (en) * 2003-02-11 2005-11-23 Torrent Pharmaceuticals Ltd Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
CN1263450C (zh) * 2005-01-20 2006-07-12 北京科信必成医药科技发展有限公司 奥美拉唑及其衍生物的口腔崩解片及其制备工艺
TWI414322B (zh) * 2007-04-26 2013-11-11 Eisai R&D Man Co Ltd Preparation of lozenges
WO2008140459A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
EP2044932A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Mechanical protective layer for solid dosage forms

Similar Documents

Publication Publication Date Title
JP2018118936A5 (https=)
JP2021509912A5 (https=)
JP2017105763A5 (https=)
WO2016131067A3 (en) Pharmaceutical compositions comprising meloxicam
JP2018064407A5 (https=)
CL2018001686A1 (es) Métodos y composiciones particularmente para el tratamiento del trastorno por déficit de atención (divisional solicitud 201701026)
MX367260B (es) Tabletas de rucaparib de dosificación elevada.
EP3417861A4 (en) PHARMACEUTICAL COMPOSITION WITH JAK KINASEINHIBITOR OR PHARMACEUTICALALLY SALT OF IT
TN2013000229A1 (en) Orally disintegrating tablet
JP2016510130A5 (https=)
CR20160192A (es) Formulación de farmaco de liberación retardada
EA201690679A1 (ru) Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан
MX2018001209A (es) Tableta.
JP2019046850A5 (https=)
WO2011140446A3 (en) Pharmaceutical formulations
JP2018041788A5 (https=)
JP2015510928A5 (https=)
EP2234598C0 (fr) Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
PL4072533T3 (pl) Postać dawkowania zawierająca środek zasadowy i warstwę powłoki dojelitowej
PL3678692T3 (pl) Stratyfikacja genotypów w leczeniu i profilaktyce cukrzycy
EP3630113A4 (en) PHARMACEUTICAL COMPOSITION INCLUDING A PDE9 INHIBITOR
JP2022536655A5 (https=)
JP2016513680A5 (https=)
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
CL2017003350A1 (es) Composiciones farmacéuticas sólidas para el tratamiento del vhc